ARCANGELI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 123
AS - Asia 63
EU - Europa 61
SA - Sud America 6
AF - Africa 1
OC - Oceania 1
Totale 255
Nazione #
US - Stati Uniti d'America 121
SG - Singapore 40
IE - Irlanda 20
RU - Federazione Russa 10
DE - Germania 9
HK - Hong Kong 8
IT - Italia 6
BR - Brasile 5
FI - Finlandia 5
VN - Vietnam 4
BD - Bangladesh 3
CN - Cina 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
GB - Regno Unito 2
IN - India 2
PL - Polonia 2
CA - Canada 1
CZ - Repubblica Ceca 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 255
Città #
Chandler 29
Dublin 20
Singapore 20
Dallas 11
Jacksonville 11
Hong Kong 8
Ann Arbor 7
Ashburn 6
Los Angeles 6
Santa Clara 6
Munich 5
Boardman 4
Helsinki 3
Lawrence 3
Princeton 3
Wilmington 3
Brussels 2
Chicago 2
Dong Ket 2
Ho Chi Minh City 2
Lappeenranta 2
New York 2
San Mateo 2
Al Ain City 1
Barretos 1
Bratsk 1
Bremen 1
Brno 1
Brooklyn 1
Cabimas 1
Chennai 1
Dearborn 1
Des Moines 1
Frankfurt am Main 1
Hamilton 1
Jeddah 1
Lithonia 1
London 1
Maricá 1
Mexico City 1
Montreal 1
Osvaldo Cruz 1
Passo Fundo 1
Patos de Minas 1
Poplar 1
Pretoria 1
Rostov-on-Don 1
The Dalles 1
Thrissur 1
Warsaw 1
Totale 186
Nome #
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 95
Tube or not tube in COVID-19 positive patients: that is the question 86
USE OF A MODIFIED SYSTEM FOR MANUAL VENTILATION OF THE PATIENT FOR IN-HOSPITAL AND EXTRA HOSPITAL TRANSPORT TO AVOID AEROSOLIZING SPREAD OF DROPLETS DURING COVID-19 OUTBREAK 78
Totale 259
Categoria #
all - tutte 1.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 4 1 2 0 7 2
2021/202214 0 1 0 0 1 0 0 2 1 0 2 7
2022/202366 5 7 1 9 8 7 0 2 25 0 0 2
2023/202410 1 2 1 0 1 2 0 0 0 1 0 2
2024/202571 1 5 5 3 7 5 8 4 18 2 8 5
2025/202669 11 17 3 14 21 3 0 0 0 0 0 0
Totale 259